Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase β

Molecular Pharmacology

Volumn 67, Issue 5, 2005, Pages 1485-1492

  Boudsocq, F ^a   Benaim, P ^a   Canitrot, Y ^a   Knibiehler, M ^b   Ausseil, F ^b   Capp, J P ^a   Bieth, A ^a   Long, C ^b   David, B ^b   Shevelev, I ^d   Frierich Heinecken, E ^c   Hubscher U ^c   Amalric, F ^b   Massiot, G ^b   Hoffmann, J S ^a   Cazaux, Christophe ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CNRS   (France)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UMR CNRS no 5089 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COMMUNIC ACID; DNA DIRECTED DNA POLYMERASE BETA; LYSINE; MAHUREONE A; MASTICADIENONIC ACID; PLANT EXTRACT; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; ENZYME BINDING; ENZYME REGULATION; GENETIC STABILITY; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL PROLIFERATION; CISPLATIN; DNA POLYMERASE BETA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HELA CELLS; HUMANS; JUNIPERUS; PISTACIA; PLANT EXTRACTS; PLANT LEAVES; PLANT STEMS; RATS;

EID: 20944441517     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.001776     Document Type: Article

References (47)

1. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2:35-43.
2. Andrews PA, Murphy MP, and Howell SB (1985) Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45:6250-6253.
3. Arya VP, Enzell C, Erdtman H, and Kubota T (1961) Communic acid, a new diterpene acid from Juniperus communis. Acta Chem Scand 225-226.
4. Barton DHR and Soane E (1956) The constitution and stereochemistry of masticadienonic acid. J Chem Soc 4150-4157.
5. Bergoglio V, Canitrot Y, Hogarth L, Minto L, Howell SB, Cazaux C, and Hoffmann JS (2001) Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene 20:6181-6187.
6. Bergoglio V, Ferrari E, Hubscher U, Cazaux C, and Hoffmann JS (2003) DNA polymerase beta can incorporate ribonucleotides during DNA synthesis of undamaged and CPD-damaged DNA. J Mol Biol 29:1017-1023.
7. Bergoglio V, Pillaire MJ, Lacroix-Triki M, Raynaud-Messina B, Bieth A, Canitrot Y, Gares M, Wright M, Delsol G, Loeb L, et al. (2002) Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res 62:3511-3514.
8. Bokesch HR, Groweiss A, McKee TC, and Boyd MR (1999) Laxifloranone, a new phloroglucinol derivative from Marila laxiflora. J Nat Prod 62:1197-1199.
9. Bouayadi K, Hoffmann JS, Fons P, Tiraby M, Reynes JP, and Cazaux C (1997) Overexpression of DNA polymerase β sensitizes mammalian cells to 2′,3′-dideoxycytidine and 3′-azido-3′-deoxythymidine. Cancer Res 57:110-116.
10. Canitrot Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B, and Hoffmann JS (1998) Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci USA 95:12586-12590.
11. Canitrot Y, Hoffmann JS, Calsou P, Hayakawa H, Salles B, and Cazaux C (2000) Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. FASEB J 14:1765-1774.
12. Canitrot Y, Lautier D, Laurent G, Fréchet M, Ahmed A, Turhan AG, Salles B, Cazaux C, and Hoffmann JS (1999) Mutator phenotype of BCR-ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase β. Oncogene 18:2876-2880.
13. Copeland WC, Chen MS, and Wang TSF (1992) Human DNA polymerases α and β are able to incorporate anti-HIV deoxynucleotides into DNA. J Biol Chem 267:21459-21464.
14. Deng JZ, Starck SR, Sun A, Salat M, and Hecht SM (2000) A new 7,8-euphadien-type triterpenoid from Brackenridgea nitida and Bleasdalea bleasdalei that inhibits DNA polymerase beta. J Nat Prod 63:1357-1361.
15. Garcia-Diaz M, Bebenek K, Kunkel TA, and Blanco L (2001) Identification of an intrinsic 5′-deoxyribose-5′-phosphate lyase activity in human DNA polymerase lambda: a possible role in base excision repair. J Biol Chem 276:34659-34663.
16. Garcia-Diaz M, Bebenek K, Sabariegos R, Dominguez O, Rodriguez J, Kirchhoff T, Garcia-Palomero E, Picher AJ, Juarez R, Ruiz JF, et al. (2002) DNA polymerase 32 λ, a novel DNA repair enzyme in human cells. J Biol Chem 277:13184-13191.
17. Hoffmann JS, Pillaire MJ, Garcia-Estefania D, Lapalu S, and Villani G (1996) In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase β and human immunodeficiency virus type I reverse transcriptase is highly mutagenic. J Biol Chem 271:15386-15392.
18. Hoffmann JS, Pillaire MJ, Maga G, Podust V, Hübscher U, and Villani G (1995) DNA polymerase β bypass in vitro d(GpG)-cisplatin adduct placed on codon 13 of H-ras gene. Proc Natl Acad Sci USA 92:5356-5360.
19. Horton JK, Baker A, Vande Berg BJ, Sobol RW, and Wilson SH (2002) Involvement of DNA polymerase beta in protection against cytotoxicity of oxydative damage. DNA Repair 1:317-333.
20. Hu HY, Horton JK, Gryk MR, Prasad R, Naron JM, Sun DA, Hecht SM, Wilson SH, and Mullen GP (2004) Identification of small molecule synthetic inhibitors of DNA polymerase β by NMR chemical shift mapping. J Biol Chem 279:39736-39744.
21. Hubscher U, Maga G, and Spadari S (2002) Eukaryotic DNA polymerases. Annu Rev Biochem 71:133-163.
22. Jekunen AP, Hom DK, Alcaraz JE, Eastman A, and Howell SB (1994) Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Res 54:2680-2687.
23. Louat T, Servant L, Rols MP, Teissie J, Hoffmann JS, and Cazaux C (2001) Antitumor activity of 2′,3′-dideoxycytidine nucleotide analog against tumors upregulating DNA polymerase beta. Mol Pharmacol 60:553-558.
24. Maciejewski MW, Liu D, Prasad R, Wilson SH, and Mullen GP (2000) Backbone dynamics and refined solution structure of the N-terminal domain of DNA polymerase beta. Correlation with DNA binding and dRP lyase activity. J Mol Biol 296:229-253.
25. Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, and Chaney SG (1994) Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 54:3500-3505.
26. Mizushina Y, Kamisuki S, Kasai N, Shimazaki N, Takemura M, Asahara H, Linn S, Yoshida S, Matsukage A, Koiwai O, et al. (2002) A plant phytotoxin, solanapyrone A, is an inhibitor of DNA polymerase beta and lambda. J Biol Chem 277:630-638.
27. Mizushina Y, Takahashi N, Ogawa A, Tsurugaya K, Koshino H, Takemura M, Yoshida S, Matsukage A, Sugawara F, and Sakaguchi K (1999) The cyanogenic glucoside, prunasin (D-mandelonitrile-beta-D-glucoside), is a novel inhibitor of DNA polymerase beta. J Biochem 126:430-436.
28. Nicholls A, Sharp KA, and Honig B (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-296.
29. Pil P and Lippard S (1997) Encyclopedia of Cancer. Academic Press, San Diego.
30. Podust VN, Chang LS, Ott R, Dianov GL, and Fanning E (2002) Reconstitution of human DNA polymerase using recombinant baculoviruses. J Biol Chem 277:3894-3901.
31. Prasad R, Beard WA, Chyan JY, Maciejewski MW, Mullen GP, and Wilson SH (1998) Functional analysis of the amino-terminal 8-kDa domain of DNA polymerase beta as revealed by site-directed mutagenesis. DNA binding and 5′-deoxyribose phosphate lyase activities. J Biol Chem 273:11121-11126.
32. Preston B, Poiesz B, and Loeb L (1988) Fidelity of HIV-1 reverse transcriptase. Science (Wash DC) 242:1168-1171.
33. Raaphorst G, Ng C, and Yang D (2002) Comparison of response to radiation, hyperthermia and cisplatin in parental and polymeraae beta knockout cells. Int J Hyperthermia 18:33-39.
34. Radman M (1999) Enzymes of evolutionary change. Nature (Lond) 401:866-868.
35. Ramadan K, Maga G, Shevelev I, Villani G, Blanco L, and Hubscher U (2003) Human DNA polymerase lambda possesses terminal deoxyribonucleotidyl transferase activity and can elongate RNA primers: implications for novel functions. J Mol Biol 328:63-72.
36. Roberts J, Nguyen D, and Kunkel T (1993) Frameshift fidelity during replication of double-stranded DNA in HeLa cell extracts. Biochemistry 32:4083-4089.
37. Sawaya MR, Prasad R, Wilson SH, Kraut J, and Pelletier H (1997) Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry 36:11205-11215.
38. Scanlon KJ, Kashani-Sabet M, and Miyachi H (1989) Differential gene expression in human cancer cells resistant to cisplatin. Cancer Investig 7:581-587.
39. Servant L, Bieth A, Cazaux C, and Hoffmann JS (2002a) Involvement of DNA polymerase beta in DNA replication and mutagenic consequences. J Mol Biol 315:1039-1047.
40. Servant L, Cazaux C, Bieth A, Iwai S, Hanaoka F, and Hoffmann JS (2002b) A role for DNA polymerase β in mutagenic UV lesion bypass. J Biol Chem 277:50046-50053.
41. Skandalis A and Loeb LA (2001) Enzymatic properties of rat DNA polymerase beta mutants obtained by randomized mutagenesis. Nucleic Acids Res 29:2418-2426.
42. Sobol RW, Horton JK, Kühn R, Gu H, Singhal RK, Prasad R, Rajewsky K, and Wilson SH (1996) Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature (Lond) 379:183-186.
43. Srivastava DK, Husain I, Arteaga CL, and Wilson SH (1999) DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis 20:1049-1054.
44. Sugo N, Aratani Y, Nagashima Y, Kubota Y, and Koyama H (2000) Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO (Eur Mol Biol Organ) J 15:1397-1404.
45. Vaisman A and Chaney SG (2000) The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase β. J Biol Chem 275:13017-13025.
46. Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle DC, Turchi JJ, and Chaney SG (1999) Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. Biochemistry 38:11026-11039.
47. Zhang JH, Chung TD, and Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67-73.